leadf
logo-loader
viewBioSig Technologies, Inc.
(
NASDAQ:BSGM
)

BioSig forms R&D program with Mayo Clinic to develop AI and machine learning for its PURE EP System

BioSig Technologies, Inc. (NASDAQ: BSGM) Executive Vice President Natasha Drapeau tells Proactive the Westport, Connecticut-based medical technology company has formed its fifth R&D program collaboration with the Mayo Foundation for Medical Education and Research. Drapeau explains how the program will aim to develop Artificial Intelligence and machine learning-powered software for its PURE EP system.

Quick facts: BioSig Technologies, Inc.

Follow
NASDAQ:BSGM

Price: 2.85 USD

Market Cap: $99.53 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

BioSig to install its PURE EP System at St. Elizabeth’s Medical Center in...

BioSig Technologies Inc Natasha Drapeau tells Proactive it would install a PURE EP System for evaluation at St. Elizabeth’s Medical Center in Boston. Drapeau says it initiated the new evaluation program under the leadership of Dr. Michael Orlov and aims to assess the PURE EP System during a...

1 day, 23 hours ago

2 min read